Revenue YoY
+8.13%
Operating Income YoY
+18.67%
Net Income YoY
+16.60%
Net Margin Δ
+269 bps
Net income bridge for Novo Nordisk (NVO) — TTM through Q1 2026 vs TTM through Q1 2025
Δ Net income: $17.34B+16.60%
Profit bridge breakdown for Novo Nordisk (NVO) — TTM through Q1 2026 vs TTM through Q1 2025
| Driver | Contribution | % of Δ |
|---|---|---|
| Prior Net Income | $15.05B | — |
| Revenue | $7.34B | +42.3% |
| Cost of Revenue | −$2.42B | -14.0% |
| Operating Expenses | −$1.29B | -7.4% |
| Other Income / Expense | $1.54B | +8.9% |
| Income Tax | −$1.26B | -7.3% |
| Net Income | $18.96B | — |
- Prior Net Income$15.05B
- Revenue$7.34B
- Cost of Revenue−$2.42B
- Operating Expenses−$1.29B
- Other Income / Expense$1.54B
- Income Tax−$1.26B
- Net Income$18.96B
Identity residual: $13.43B (delta between driver sum and reported ΔNI)
Want the full P&L structure?Income Statement Waterfall
Frequently asked questions
Data & methodology
Novo Nordisk (NVO) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement